European Commission approves Pfizer’s Elrexfio for multiple myeloma
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
Approximately 16,000 patients 12 years of age and older with severe sickle cell disease may now be eligible for this one-time treatment
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
India had proposed for setting up the global standards for millets
The new ECO grade is made using renewable feedstock
Subscribe To Our Newsletter & Stay Updated